Skip to main content

Articles

Melanoma, Oncology
Immunotherapies Take Center Stage in Melanoma
Read More
Cancer Drug Pipeline Is Bustling
Read More
FDA Approvals
Mekinist and Dabrafenib Approved for Advanced Melanoma with BRAF Mutations
Read More
FDA Approvals
Lenalidomide Receives New Indication for Mantle-Cell Lymphoma
Read More
Dermatology, Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Stakeholder Perspective
The Psychosocial Impact of Skin Disorders: Time for a Closer Look?
Read More
FDA Approvals
Simbrinza (Brinzolamide/Brimonidine Tartrate) Receives FDA Approval for the Treatment of Open-Angle Glaucoma or Ocular Hypertension
Read More
FDA Approvals
Ilaris (Canakinumab) Receives a New Indication for the Treatment of Systemic Juvenile Idiopathic Arthritis
Read More
Dermatology
Rosacea: A Misunderstood, Serious Medical Condition
Read More
Dermatology
Current Therapies for the Management of Patients with Rosacea
Read More
Practice Management
Rapid Expansion of New Oncology Care Delivery Payment Models: Results from a Payer Survey
Stakeholder Perspective
New Oncology Care Delivery Payment Models to Enhance Care Efficiency
Read More
Page 176 of 245
Results 1751 - 1760 of 2441